Arrigo Francesco Giuseppe Cicero: Diagnostic and Prognostic Perspectives of Glycocalyx Disruption in Pregnancy
Arrigo Francesco Giuseppe Cicero, Head and Associate Professor of Human Nutrition at Alma Mater Studiorum – University of Bologna and President at SiNut Official, shared a post on LinkedIn about a recent article he and his colleges co-authored, adding:
“I’m pleased to share our latest publication in Inflammation Research:
‘Biomarkers of endothelial glycocalyx dysfunction in pregnancy: a systematic review of clinical relevance and detection techniques’
In this work, we explored the role of the endothelial glycocalyx as a key regulator of vascular homeostasis and its involvement in pregnancy-related complications such as preeclampsia.
Key insights:
- Glycocalyx disruption is consistently associated with adverse maternal–fetal outcomes
- Circulating biomarkers (e.g., syndecan-1, hyaluronic acid, heparan sulfate) may serve as indicators of endothelial injury
- Emerging imaging techniques could support early detection and risk stratification
These findings highlight the potential of integrating glycocalyx-related biomarkers into clinical practice, opening new perspectives for cardio-obstetric care.”
Title: Biomarkers of endothelial glycocalyx dysfunction in pregnancy: a systematic review of clinical relevance and detection techniques
Authors: Federica Fogacci, Duha Yahya, Jeanine Roeters Van Lennep, Katariina Öörni, Valentina Di Micoli, Francesco De Seta, Cristina Scollo, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
Read the Full Article on Inflammation Research

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery